EDGAR Filing Documents for 0001415889-14-001143

Form 8-K - Current report:

SEC Accession No. 0001415889-14-001143

Filing Date

2014-04-08

Accepted

2014-04-08 10:11:49

Documents

Period of Report

2014-04-01

Items

Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	vsta8k_april12014.htm	8-K	30063
2	FORM OF UNIT SUBSCRIPTION AGREEMENT, DATED APRIL 1, 2014	ex10-1.htm	EX-10.1	86801
3	FORM OF SUBORDINATE CONVERTIBLE PROMISSORY BRIDGE NOTE, DATED APRIL 1, 2014	ex10-2.htm	EX-10.2	54596
4	FORM OF WARRANT, DATED APRIL 1, 2014	ex10-3.htm	EX-10.3	138509
	Complete submission text file	0001415889-14-001143.txt		311358

Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080

Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-244-9990

VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)